Beranda › Kanker Endometrium › North Carolina › Raleigh
Uji klinis Kanker Endometrium di Raleigh, NC
5 studi untuk Kanker Endometrium mencari peserta di lokasi sekitar Raleigh (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Menerima pesertaFase 3
- Duke Women's Cancer Care Raleigh, Raleigh
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Menerima pesertaFase 2
- Duke Women's Cancer Care Raleigh, Raleigh
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
Menerima pesertaFase 2
- Duke Women's Cancer Care Raleigh, Raleigh
Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
Menerima pesertaFase 2
- Duke Womens Cancer Care Raleigh, Raleigh
Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
Menerima pesertaFase 1
- Investigative Site #131, Raleigh
Uji klinis Kanker Endometrium di kota lain
- Houston, TX68 studi
- New York City, NY52 studi
- Boston, MA50 studi
- Arlington, VA39 studi
- Nashville, TN38 studi
- Los Angeles, CA34 studi
- St. Louis, MO29 studi
- Philadelphia, PA28 studi
- San Antonio, TX27 studi
- Columbus, OH25 studi
- Chicago, IL25 studi
- Oklahoma City, OK25 studi
Studi lain di Raleigh
- Gagal Jantung7 studi
- Penyakit Arteri Koroner6 studi
- Obesitas6 studi
- Diabetes Tipe 26 studi
- Degenerasi Makula6 studi
- Aterosklerosis5 studi
- Kelebihan Berat Badan5 studi
- Penyakit Kardiovaskular5 studi
- Stroke5 studi
- Gagal Ginjal4 studi
- Diabetes4 studi
- Kanker Ovarium4 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.